Chronic Kidney Disease - REAL Life Study in Alsace
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Chronic Kidney Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry). Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage. Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.
Primary outcome measures
- Retroanalysis of the risk factors in patients with severe chronic kidney disease [Time frame: Files analysed retrospectively from October 01, 2019 to February 31, 2027 will be examined]
Eligibility criteria
Inclusion criteria
- Major subject (≥18 years)
- Subject included in the MRC package (GFR <30 ml/min/1.73 m2)
- Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research
Exclusion criteria
\- Subject having expressed his opposition to participate in the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
France · 1 center
- Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France — Strasbourg
Identifiers
NCT: NCT05527626 · 8517